Characterization of the humoral immune response in heparin-induced thrombocytopenia.
about
Evaluation of a pharmacy-based surveillance program for heparin-induced thrombocytopenia.New developments in diagnosis and treatment of heparin-induced thrombocytopenia.PF4/heparin complexes are T cell-dependent antigens.Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: present and future.HIT paradigms and paradoxes.Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA.Management of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia (HIT II) in liver transplant recipients: a retrospective multivariate analysis of prognostic factors.Protamine-induced immune thrombocytopenia.Critical role for mouse marginal zone B cells in PF4/heparin antibody production.B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia.Critical role of CD4 T cells in PF4/heparin antibody production in mice
P2860
Q33333542-D98804A9-7542-4F0B-90A1-89A6C329443CQ33364828-81BC2E64-58C1-4BF6-B33E-8D0298129A07Q33365918-6A5C0507-78B8-4E7E-A00D-1AF0BB5C2B2EQ33369316-41294D68-4D86-44FD-93C5-AE1C93D9108AQ33372115-52BC4A74-680C-4888-9FF0-89F555B83DF8Q33376811-F1BB4695-47CA-45C0-A968-EF68DC52AAF6Q33394188-2FDBCC6B-63E8-47C0-B3B2-2F02D8403630Q33396313-99BE6549-1945-4E7F-BA44-5110C7BF22F5Q33398047-A36119F1-4C16-42C8-A5F2-516D5E52C699Q33400573-4732EC0D-85DA-4169-BDE4-59AFEB0F8D70Q33401025-0C79A5CB-8805-49F2-9414-A1BEA7B3A841Q33405699-16A95C51-5CA4-4D2F-A307-0488F0009ED0Q33406245-E4F337BF-C893-4A7B-A88C-12AC1D559932Q33412220-F9788B1C-FBA7-45A8-900F-58BBF267272AQ33419834-19A8283A-1B88-41AA-AEE7-2237DA2DC6B2
P2860
Characterization of the humoral immune response in heparin-induced thrombocytopenia.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Characterization of the humoral immune response in heparin-induced thrombocytopenia.
@ast
Characterization of the humoral immune response in heparin-induced thrombocytopenia.
@en
type
label
Characterization of the humoral immune response in heparin-induced thrombocytopenia.
@ast
Characterization of the humoral immune response in heparin-induced thrombocytopenia.
@en
prefLabel
Characterization of the humoral immune response in heparin-induced thrombocytopenia.
@ast
Characterization of the humoral immune response in heparin-induced thrombocytopenia.
@en
P2093
P2860
P1476
Characterization of the humoral immune response in heparin-induced thrombocytopenia.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1096-8652(199703)54:3<196::AID-AJH4>3.0.CO;2-R
P577
1997-03-01T00:00:00Z